Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Is to determine if SDM laser can reduce macular thickness in non central CSME and stop the progression of non central CSME to central CSME in compare to glycemic control
interventional randomised masked study will recruit patients have diabetes mellitus with non central CSME with good vision into two groups : 1st SDM laser with glycemic control 2nd SHAM laser with Glycemic control where BCVA will be recorded every month starting from baseline to 24 weeks where OCT will be recorded every 8 weeks from baseline to 24 weeks
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Subtherhold 532 nm laser | Experimental | Applying 532nm subtherhold laser with 5% duty cycle using high density low intensity protocol at the area of non central clinical significant macular edema |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Subthreshold 532nm laser | Device | Subthershold 532nm laser |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of eyes with reduced macular thickness | Measurements of retinal thickness in the area of edema | 24 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Number of eyes with reduced vision | Best corrected visual acuity at the end of the study | 24 weeks |
| Number of eyes developing central macular edema | 24 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Marashi Eye Clinic | Aleppo | 2241511 | Syria |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| Result | Marashi A. Non-central diabetic clinical significant macular edema treatment with 532nm sub threshold laser. Adv Ophthalmol Vis Syst. 2018;8(3):151-154. DOI: 10.15406/aovs.2018.08.0029 |
| Label | URL |
|---|---|
| Non-central diabetic clinical significant macular edema treatment with 532nm sub threshold laser | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007834 | Lasers |
| ID | Term |
|---|---|
| D055096 | Optical Devices |
| D004864 | Equipment and Supplies |
| D055618 | Radiation Equipment and Supplies |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Number of patients achieved good glycemic control | By measuring HbA1C every 12 weeks from baseline | 24 weeks |